Health Trials

High Grade Serous Ovarian Carcinoma

2

Review clinical trials related to High Grade Serous Ovarian Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Jun 11, 2026Locations: 13
Eligibility criteria

Participant ≥ 18 year [+12]

History or planned organ or allogeneic stem cell transplantation. [+11]

Read more
Status: Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

The goal of this study is to identify a safe and tolerated dose of the orally administered KIF18A inhibitor ATX-295. In addition, this study will evaluate the pharmacokinetics, pharmacodynamics and preliminary antitumor activity of ATX-295 in patients with advanced solid tumors and ovarian cancer.

Participants needed: 90
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Accent TherapeuticsUpdated: Feb 24, 2026Locations: 5
Eligibility criteria

Patients with histologically confirmed solid tumors who have locally recurrent o... [+5]

Clinically unstable central nervous system (CNS) tumors or brain metastasis [+7]

Read more